Updated Jul 16, 2026
Sagartz John E has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $616.
John E. Sagartz is a corporate executive associated with Inotiv, Inc., a company specializing in preclinical and clinical research services. Specific details about his career and contributions to the company are limited in public records.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | NOTV | Inotiv, Inc. | F — Tax withholding / forfeiture | 6.1K | $0.02 | $112 |
| 2026-02-19 | NOTV | Inotiv, Inc. | S — Open-market sale [10b5-1] | 2.1K | $0.29 | $616 |
John E. Sagartz is a corporate executive associated with Inotiv, Inc., a company specializing in preclinical and clinical research services. Specific details about his career and contributions to the company are limited in public records.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($616) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sagartz John E profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.